93 related articles for article (PubMed ID: 3757409)
1. The disposition and dynamics of labetalol in patients on dialysis.
Halstenson CE; Opsahl JA; Pence TV; Luke DR; Sirgo MA; Plachetka JR; Abraham PA; Matzke GR
Clin Pharmacol Ther; 1986 Oct; 40(4):462-8. PubMed ID: 3757409
[TBL] [Abstract][Full Text] [Related]
2. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
[TBL] [Abstract][Full Text] [Related]
3. Labetalol disposition and concentration-effect relationships during pregnancy.
Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.
Ortega O; Gallar P; Carreño A; Gutierrez M; Rodriguez I; Oliet A; Vigil A; Gimenez E
Am J Nephrol; 2001; 21(3):189-93. PubMed ID: 11423687
[TBL] [Abstract][Full Text] [Related]
5. Disposition of foscarnet during peritoneal dialysis.
Alexander AC; Akers A; Matzke GR; Aweeka FT; Fraley DS
Ann Pharmacother; 1996 Oct; 30(10):1106-9. PubMed ID: 8893116
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
7. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
Brouard RJ; Kapusnik JE; Gambertoglio JG; Schoenfeld PY; Sachdeva M; Freel K; Tozer TN
Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
[TBL] [Abstract][Full Text] [Related]
8. Similarities in functional state of the kidney in patients treated with CAPD and hemodialysis.
van Olden RW; Krediet RT; Struijk DG; Arisz L
Adv Perit Dial; 1996; 12():97-100. PubMed ID: 8865881
[TBL] [Abstract][Full Text] [Related]
9. The effect of hemodialysis on piperacillin pharmacokinetics.
Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and undergoing hemodialysis or CAPD.
Kowalsky SF; Echols M; Schwartz MT; Bailie GR; McCormick E
Clin Nephrol; 1993 Jan; 39(1):53-8. PubMed ID: 8428409
[TBL] [Abstract][Full Text] [Related]
11. The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.
Daneshmend TK; Roberts CJ
Br J Clin Pharmacol; 1984 Sep; 18(3):393-400. PubMed ID: 6487478
[TBL] [Abstract][Full Text] [Related]
12. Chronic renal replacement therapy in children: which index is best for adequacy?
Verrina E; Brendolan A; Gusmano R; Ronco C
Kidney Int; 1998 Nov; 54(5):1690-6. PubMed ID: 9844146
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis.
Shah GM; Winer RL; Krasny HC
Am J Kidney Dis; 1986 Jun; 7(6):507-10. PubMed ID: 3717158
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of clodronate in peritoneal dialysis patients.
Saha HH; Ala-Houhala IO; Liukko-Sipi SH; Ylitalo P; Pasternack AI
Perit Dial Int; 1998; 18(2):204-9. PubMed ID: 9576370
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.
Takeda K; Nakamoto M; Baba M; Tanaka T; Yasunaga C; Nishihara G; Matsuo K; Urabe M
Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of esmolol and ASL-8123 in renal failure.
Flaherty JF; Wong B; La Follette G; Warnock DG; Hulse JD; Gambertoglio JG
Clin Pharmacol Ther; 1989 Mar; 45(3):321-7. PubMed ID: 2563962
[TBL] [Abstract][Full Text] [Related]
17. Fluid state and blood pressure control: no differences between APD and CAPD.
Cnossen TT; Konings CJ; Fagel WJ; van der Sande FM; van Geel K; Leunissen KM; Kooman JP
ASAIO J; 2012; 58(2):132-6. PubMed ID: 22370683
[TBL] [Abstract][Full Text] [Related]
18. Plasma and peritoneal endothelin levels and blood pressure in CAPD patients with or without erythropoietin replacement therapy.
Lebel M; Moreau V; Grose JH; Kingma I; Langlois S
Clin Nephrol; 1998 May; 49(5):313-8. PubMed ID: 9617496
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
